PMAM
ABBV icon

Picton Mahoney Asset Management’s AbbVie ABBV Stock Holding History

Picton Mahoney Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-24,000
Closed -$2.27M – 183
2018
Q1 		$2.27M Buy
+24,000
New +$2.64M 0.16% 116

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Picton Mahoney Asset Management's ABBV Position: Q1 2026 in Review

Picton Mahoney Asset Management reduced its AbbVie (ABBV) stake by 11% in Q1 2026, selling an estimated $1.67M and leaving 62,704 shares worth $13.6M. The position accounts for 0.1% of the portfolio, ranked #187.

Picton Mahoney Asset Management first reported a position in ABBV in Q2 2013 and has held it in 21 quarters since. The position peaked at $26.3M in Q1 2014. 4,090 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Picton Mahoney Asset Management held 62,704 shares of AbbVie worth $13.6M as of Q1 2026.
  • Picton Mahoney Asset Management sold 7,527 AbbVie shares in Q1 2026, an estimated $1.67M.
  • AbbVie made up 0.1% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #187 holding.
  • Picton Mahoney Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 21 quarters since.
  • Picton Mahoney Asset Management's AbbVie position peaked at $26.3M in Q1 2014.
  • 4,090 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.